{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:58:55Z","timestamp":1780491535878,"version":"3.54.1"},"reference-count":41,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2013,10,24]],"date-time":"2013-10-24T00:00:00Z","timestamp":1382572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DK090019"],"award-info":[{"award-number":["DK090019"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,24]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>While there have been significant advances in our understanding of the autoimmune responses and the molecular nature of the target autoantigens in primary biliary cirrhosis (PBC), unfortunately these data have yet to be translated into new therapeutic agents. We have taken advantage of a unique murine model of autoimmune cholangitis in which mice expressing a dominant negative form of transforming growth factor \u03b2 receptor II (dnTGF\u03b2RII), under the control of the CD4 promoter, develop an intense autoimmune cholangitis associated with serological features similar to human PBC. CD40-CD40 ligand (CD40L) is a major receptor\u2013ligand pair that provides key signals between cells of the adaptive immune system, prompting us to determine the therapeutic potential of treating autoimmune cholangitis with anti-CD40L antibody (anti-CD40L; MR-1). Four-week-old dnTGF\u03b2RII mice were injected intraperitoneally with either anti-CD40L or control immunoglobulin (Ig)G at days 0, 2, 4 and 7 and then weekly until 12 or 24 weeks of age and monitored for the progress of serological and histological features of PBC, including rigorous definition of liver cellular infiltrates and cytokine production. Administration of anti-CD40L reduced liver inflammation significantly to 12 weeks of age. In addition, anti-CD40L initially lowered the levels of anti-mitochondrial autoantibodies (AMA), but these reductions were not sustained. These data indicate that anti-CD40L delays autoimmune cholangitis, but the effect wanes over time. Further dissection of the mechanisms involved, and defining the events that lead to the reduction in therapeutic effectiveness will be critical to determining whether such efforts can be applied to PBC.<\/jats:p>","DOI":"10.1111\/cei.12193","type":"journal-article","created":{"date-parts":[[2013,8,27]],"date-time":"2013-08-27T12:06:56Z","timestamp":1377605216000},"page":"364-371","source":"Crossref","is-referenced-by-count":43,"title":["Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis"],"prefix":"10.1093","volume":"174","author":[{"given":"H","family":"Tanaka","sequence":"first","affiliation":[{"name":"Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CA, USA"},{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G-X","family":"Yang","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Iwakoshi","sequence":"additional","affiliation":[{"name":"Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S J","family":"Knechtle","sequence":"additional","affiliation":[{"name":"Department of Surgery, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kawata","sequence":"additional","affiliation":[{"name":"Hepatology Division, Hamamatsu University School of Medicine, Shizuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tsuneyama","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CA, USA"},{"name":"Department of Diagnostic Pathology, Graduate School of Medicine and Pharmaceutical Science for Research, University of Toyama, Toyama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Leung","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R L","family":"Coppel","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Monash University, Melbourne, Vic., Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Ansari","sequence":"additional","affiliation":[{"name":"Department of Pathology, Emory University School of Medicine, Atlanta, GA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Joh","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bowlus","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology and Hepatology, University of California at Davis School of Medicine, Sacramento, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M E","family":"Gershwin","sequence":"additional","affiliation":[{"name":"Division of Rheumatology, Allergy and Clinical Immunology, University of California at Davis, Davis, CA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,24]]},"reference":[{"key":"2021122009584102400_cei12193-bib-0001","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1034\/j.1600-0528.2002.017402.x","article-title":"Primary biliary cirrhosis: an orchestrated immune response against epithelial cells","volume":"174","author":"Gershwin","year":"2000","journal-title":"Immunol Rev"},{"key":"2021122009584102400_cei12193-bib-0002","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/hep.22042","article-title":"The causes of primary biliary cirrhosis: convenient and inconvenient truths","volume":"47","author":"Gershwin","year":"2008","journal-title":"Hepatology"},{"key":"2021122009584102400_cei12193-bib-0003","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12016-012-8323-1","article-title":"Immunological orchestration of liver fibrosis","volume":"43","author":"Tanaka","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"key":"2021122009584102400_cei12193-bib-0004","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1172\/JCI4213","article-title":"Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis","volume":"102","author":"Shimoda","year":"1998","journal-title":"J Clin Invest"},{"key":"2021122009584102400_cei12193-bib-0005","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1084\/jem.20010956","article-title":"Identification of HLA-A2-restricted CD8(+) cytotoxic T cell responses in primary biliary cirrhosis: T cell activation is augmented by immune complexes cross-presented by dendritic cells","volume":"195","author":"Kita","year":"2002","journal-title":"J Exp Med"},{"key":"2021122009584102400_cei12193-bib-0006","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1172\/JCI0214698","article-title":"Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis","volume":"109","author":"Kita","year":"2002","journal-title":"J Clin Invest"},{"key":"2021122009584102400_cei12193-bib-0007","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/hep.22226","article-title":"Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice","volume":"47","author":"Yang","year":"2008","journal-title":"Hepatology"},{"key":"2021122009584102400_cei12193-bib-0008","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1053\/j.gastro.2008.11.035","article-title":"B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis","volume":"136","author":"Moritoki","year":"2009","journal-title":"Gastroenterology"},{"key":"2021122009584102400_cei12193-bib-0009","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/ni.2079","article-title":"Autocrine IL-2 is required for secondary population expansion of CD8(+) memory T cells","volume":"12","author":"Feau","year":"2011","journal-title":"Nat Immunol"},{"key":"2021122009584102400_cei12193-bib-0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1146\/annurev.immunol.16.1.111","article-title":"CD40 and CD154 in cell-mediated immunity","volume":"16","author":"Grewal","year":"1998","journal-title":"Annu Rev Immunol"},{"key":"2021122009584102400_cei12193-bib-0011","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/BF02256091","article-title":"The role of CD40\u2013CD154 interaction in cell immunoregulation","volume":"11","author":"Xu","year":"2004","journal-title":"J Biomed Sci"},{"key":"2021122009584102400_cei12193-bib-0012","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.smim.2009.05.012","article-title":"CD40 and autoimmunity: the dark side of a great activator","volume":"21","author":"Peters","year":"2009","journal-title":"Semin Immunol"},{"key":"2021122009584102400_cei12193-bib-0013","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40\u2013CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"2021122009584102400_cei12193-bib-0014","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10067-006-0389-9","article-title":"The levels of sCD30 and of sCD40L in a group of patients with systemic lupus erythematodes and their diagnostic value","volume":"26","author":"Ciferska","year":"2007","journal-title":"Clin Rheumatol"},{"key":"2021122009584102400_cei12193-bib-0015","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jaut.2006.02.002","article-title":"Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases","volume":"26","author":"Goules","year":"2006","journal-title":"J Autoimmun"},{"key":"2021122009584102400_cei12193-bib-0016","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/1529-0131(199905)42:5<871::AID-ANR5>3.0.CO;2-J","article-title":"Elevated levels and functional capacity of soluble CD40 ligand in systemic lupus erythematosus sera","volume":"42","author":"Vakkalanka","year":"1999","journal-title":"Arthritis Rheum"},{"key":"2021122009584102400_cei12193-bib-0017","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00384-002-0425-4","article-title":"Plasma levels of soluble CD40 ligand are elevated in inflammatory bowel diseases","volume":"18","author":"Ludwiczek","year":"2003","journal-title":"Int J Colorect Dis"},{"key":"2021122009584102400_cei12193-bib-0018","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1478-3231.2005.01211.x","article-title":"The relationship between hepatic immunoglobulin production and CD154 expression in chronic liver diseases","volume":"26","author":"Mayo","year":"2006","journal-title":"Liver Int"},{"key":"2021122009584102400_cei12193-bib-0019","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1096\/fj.01-0088com","article-title":"CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB\/AP-1 signaling in human intrahepatic biliary epithelial cells","volume":"15","author":"Afford","year":"2001","journal-title":"FASEB J"},{"key":"2021122009584102400_cei12193-bib-0020","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/hep.24630","article-title":"Immunoglobulin M levels inversely correlate with CD40 ligand promoter methylation in patients with primary biliary cirrhosis","volume":"55","author":"Lleo","year":"2012","journal-title":"Hepatology"},{"key":"2021122009584102400_cei12193-bib-0021","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.4049\/jimmunol.177.3.1655","article-title":"Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice","volume":"177","author":"Oertelt","year":"2006","journal-title":"J Immunol"},{"key":"2021122009584102400_cei12193-bib-0022","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/hep.25829","article-title":"Deletion of interleukin (IL)-12p35 induces liver fibrosis in dominant-negative TGFbeta receptor type II mice","volume":"57","author":"Tsuda","year":"2013","journal-title":"Hepatology"},{"key":"2021122009584102400_cei12193-bib-0023","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.22390","article-title":"Loss of tolerance in C57BL\/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease","volume":"48","author":"Wakabayashi","year":"2008","journal-title":"Hepatology"},{"key":"2021122009584102400_cei12193-bib-0024","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1002\/hep.23238","article-title":"B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice","volume":"50","author":"Moritoki","year":"2009","journal-title":"Hepatology"},{"key":"2021122009584102400_cei12193-bib-0025","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/hep.23132","article-title":"Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice","volume":"50","author":"Yoshida","year":"2009","journal-title":"Hepatology"},{"key":"2021122009584102400_cei12193-bib-0026","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1073\/pnas.93.6.2499","article-title":"CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis","volume":"93","author":"Gerritse","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"2021122009584102400_cei12193-bib-0027","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1126\/science.7689748","article-title":"Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40","volume":"261","author":"Durie","year":"1993","journal-title":"Science"},{"key":"2021122009584102400_cei12193-bib-0028","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.4049\/jimmunol.154.3.1470","article-title":"Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis","volume":"154","author":"Mohan","year":"1995","journal-title":"J Immunol"},{"key":"2021122009584102400_cei12193-bib-0029","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4049\/jimmunol.157.1.417","article-title":"Autoimmune lpr\/lpr mice deficient in CD40 ligand: spontaneous Ig class switching with dichotomy of autoantibody responses","volume":"157","author":"Ma","year":"1996","journal-title":"J Immunol"},{"key":"2021122009584102400_cei12193-bib-0030","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nn968","article-title":"Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice","volume":"5","author":"Tan","year":"2002","journal-title":"Nat Neurosci"},{"key":"2021122009584102400_cei12193-bib-0031","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1074-7613(00)80170-3","article-title":"Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease","volume":"12","author":"Gorelik","year":"2000","journal-title":"Immunity"},{"key":"2021122009584102400_cei12193-bib-0032","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.1840120612","article-title":"Site-directed mutagenesis of lysine within the immunodominant autoepitope of PDC-E2","volume":"12","author":"Leung","year":"1990","journal-title":"Hepatology"},{"key":"2021122009584102400_cei12193-bib-0033","doi-asserted-by":"crossref","first-page":"233","DOI":"10.4161\/mabs.2.3.11782","article-title":"Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies","volume":"2","author":"Brennan","year":"2010","journal-title":"mAbs"},{"key":"2021122009584102400_cei12193-bib-0034","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1056\/NEJMoa074943","article-title":"Cetuximab-induced anaphylaxis and IgE specific for galactose-alpha-1,3-galactose","volume":"358","author":"Chung","year":"2008","journal-title":"N Engl J Med"},{"key":"2021122009584102400_cei12193-bib-0035","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12016-009-8140-3","article-title":"Immunogenicity of anti-TNF-alpha agents in autoimmune diseases","volume":"38","author":"Emi Aikawa","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"key":"2021122009584102400_cei12193-bib-0036","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2011.11.005","article-title":"Primary biliary cirrhosis and Sjogren's syndrome: autoimmune epithelitis","volume":"39","author":"Selmi","year":"2012","journal-title":"J Autoimmun"},{"key":"2021122009584102400_cei12193-bib-0037","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jaut.2011.05.009","article-title":"T cell clonal expansions detected in patients with primary biliary cirrhosis express CX3CR1","volume":"37","author":"Zhang","year":"2011","journal-title":"J Autoimmun"},{"key":"2021122009584102400_cei12193-bib-0038","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","article-title":"Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis","volume":"41","author":"Wang","year":"2013","journal-title":"J Autoimmun"},{"key":"2021122009584102400_cei12193-bib-0039","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jaut.2012.05.022","article-title":"The immunopathology of liver granulomas in primary biliary cirrhosis","volume":"39","author":"You","year":"2012","journal-title":"J Autoimmun"},{"key":"2021122009584102400_cei12193-bib-0040","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.4049\/jimmunol.157.7.3159","article-title":"Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black\u2009\u00d7\u2009New Zealand white mice. Response correlates with the absence of an anti-antibody response","volume":"157","author":"Early","year":"1996","journal-title":"J Immunol"},{"key":"2021122009584102400_cei12193-bib-0041","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1002\/art.11230","article-title":"Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis","volume":"48","author":"Quezada","year":"2003","journal-title":"Arthritis Rheum"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12193","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/174\/3\/364\/41789136\/cei12193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/174\/3\/364\/41789136\/cei12193.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T03:56:14Z","timestamp":1688442974000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/174\/3\/364\/6421061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,24]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2013,10,24]]},"published-print":{"date-parts":[[2013,10,24]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12193","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2013,12]]},"published":{"date-parts":[[2013,10,24]]}}}